Diabetes mellitus type 2 an independent risk factor for cancer?

Experimental and Clinical Endocrinology and Diabetes

Volumn 118, Issue 1, 2010, Pages 4-8

  Grote, V A ^a   Becker, S ^a   Kaaks, R ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Cancer; Diabetes; Metabolic features

Indexed keywords

GLUCOSE; INSULIN; C PEPTIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; METFORMIN; SEX HORMONE; SULFONYLUREA;

BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER RISK; COLORECTAL CANCER; DIABETIC PATIENT; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; KIDNEY CANCER; LIVER CANCER; MALIGNANT NEOPLASTIC DISEASE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS CANCER; PRIORITY JOURNAL; SHORT SURVEY; BODY MASS; CANCER GROWTH; CANCER LOCALIZATION; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL TRIAL; DIET RESTRICTION; HORMONE METABOLISM; HUMAN; INSULIN METABOLISM; INSULINEMIA; INTRAABDOMINAL FAT; KIDNEY TUMOR; PROSTATE CANCER; RISK FACTOR; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; HUMANS; HYPERGLYCEMIA; HYPERINSULINISM; HYPOGLYCEMIC AGENTS; MALE; NEOPLASMS; OBESITY; RISK FACTORS;

EID: 76749106139     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0029-1243193     Document Type: Short Survey

References (43)

1. Anderson KE, Anderson E, etal. Diabetes and endometrial cancer in the Iowa women's health study. Cancer Epidemiol Biomarkers Prev 2001 10 611-616
2. Becker S, Dossus L, etal. Obesity related hyperinsulinaemia and hyperglycaemia and cancer development. Arch Physiol Biochem 2009 115 86-96
3. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004 4 579-591
4. Colhoun HM. Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia 2009 52 1755-1765
5. Cust AE, Kaaks R, etal. Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 2007 14 755-767
6. Frasca F, Pandini G, etal. The role of insulin receptors and IGF-I receptors in cancer and other diseases. Arch Physiol Biochem 2008 114 23-37
7. Friberg E, Orsini N, etal. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 2007 50 1365-1374
8. Gapstur SM, Gann PH, etal. Abnormal glucose metabolism and pancreatic cancer mortality. JAMA 2000 283 2552-2558
9. Giovannucci E. Nutrition, insulin, insulin-like growth factors and cancer. Horm Metab Res 2003 35 694-704
10. Hemkens LG, Grouven U, etal. Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study. Diabetologia 2009 52 1732-1744
11. Huxley R, Ansary-Moghaddam A, etal. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 2005 92 2076-2083
12. th 2009). Diabetes Atlas 2009, from http://www.eatlas.idf.org/atlasff5d.html?id=0.
13. Inoue M, Iwasaki M, etal. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 2006 166 1871-1877
14. Jee SH, Ohrr H, etal. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005 293 194-202
15. Jonasson JM, Ljung R, etal. Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden. Diabetologia 2009 52 1745-1754
16. Kaaks R, Lukanova A. Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc 2001 60 91-106
17. Kaaks R, Lukanova A, etal. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 2002 11 1531-1543
18. Kabat GC, Kim M, etal. Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer. Int J Cancer 2009 125 2704-2710
19. Kahn SE, Hull RL, etal. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006 444 840-846
20. Kasper JS, Giovannucci E. A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006 15 2056-2062 (Pubitemid 44877026)
21. Kolonel LN, Altshuler D, etal. The multiethnic cohort study: exploring genes, lifestyle and cancer risk. Nat Rev Cancer 2004 4 519-527
22. Larsson SC, Mantzoros CS, etal. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 2007 121 856-862
23. Larsson SC, Orsini N, etal. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 2005 97 1679-1687
24. Leitzmann MF, Ahn J, etal. Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Causes Control 2008 19 1267-1276
25. Libby G, Donnelly LA, etal. New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care 2009 32 1620-1625
26. Luo Z, Saha AK, etal. AMPK, the metabolic syndrome and cancer. Trends Pharmacol Sci 2005 26 69-76
27. Mayer D, Shukla A, etal. Proliferative effects of insulin analogues on mammary epithelial cells. Arch Physiol Biochem 2008 114 38-44
28. Mink PJ, Shahar E, etal. Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study. Am J Epidemiol 2002 156 349-352
29. Mori M, Saitoh S, etal. A Review of Cohort Studies on the Association Between History of Diabetes Mellitus and Occurrence of Cancer. Asian Pac J Cancer Prev 2000 1 269-276
30. Muti P, Quattrin T, etal. Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 2002 11 1361-1368
31. Pannala R, Basu A, etal. New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol 2009 10 88-95
32. Parkin DM, Bray F, etal. Global cancer statistics, 2002. CA Cancer J Clin 2005 55 74-108
33. Pisani P. Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. Arch Physiol Biochem 2008 114 63-70
34. Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 2008 8 915-928
35. Rapp K, Schroeder J, etal. Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia 2006 49 945-952
36. Rinaldi S, Rohrmann S, etal. Glycosylated hemoglobin and risk of colorectal cancer in men and women, the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 2008 17 3108-3115
37. Rodriguez C, Patel AV, etal. Diabetes and risk of prostate cancer in a prospective cohort of US men. Am J Epidemiol 2005 161 147-152 (Pubitemid 40096789)
38. Stattin P, Bjor O, etal. Prospective study of hyperglycemia and cancer risk. Diabetes Care 2007 30 561-567 (Pubitemid 46354334)
39. Stocks T, Lukanova A, etal. Insulin resistance is inversely related to prostate cancer: a prospective study in Northern Sweden. Int J Cancer 2007 120 2678-2686
40. Stolzenberg-Solomon RZ, Graubard BI, etal. Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA 2005 294 2872-2878
41. Stumvoll M, Goldstein BJ, etal. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005 365 1333-1346
42. Wang F, Herrington M, etal. The relationship between diabetes and pancreatic cancer. Mol Cancer 2003 2 4
43. th 2009). Diabetes Facts & Figures 2009, from http://www.who.int/diabetes/facts/world-figures/en/index.html.